Dr Amy Lascelles Heibel, MD | |
1504 Ben Taub Loop, Houston, TX 77030 | |
(281) 952-0384 | |
Not Available |
Full Name | Dr Amy Lascelles Heibel |
---|---|
Gender | Female |
Speciality | Pulmonary Disease |
Experience | 9 Years |
Location | 1504 Ben Taub Loop, Houston, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093196636 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | T0230 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Harris Health System | Houston, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Baylor College Of Medicine | 8224941265 | 684 |
News Archive
In biologically active enzyme substrate compounds, as can be found in medicines, water plays a more decisive role than has been imagined up to now. The surrounding water acts like an "adhesive", in order to keep the substrate at the right place on an enzyme.
There are many people in this position and the number is increasing; cancer patients who not only have to fight against cancer, but also suffer from other diseases. So-called comorbidity is a large and growing problem, not least because we are becoming older and age increases the risk of contracting cancer as well as other diseases.
NeuroDerm, Ltd. announced today that enrollment of healthy subjects is ongoing in its Phase I clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously via a subcutaneous delivery patch device. It is designed to provide steady levodopa blood levels and enhanced bioavailability of oral levodopa for the reduction of motor complications in Parkinson's disease.
After over a decade of preclinical research and development, a new gene therapy treatment for Sickle Cell Anemia is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the world where SCA is most common.
› Verified 3 days ago
Entity Name | Baylor College Of Medicine |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053352914 PECOS PAC ID: 8224941265 Enrollment ID: O20031106000562 |
News Archive
In biologically active enzyme substrate compounds, as can be found in medicines, water plays a more decisive role than has been imagined up to now. The surrounding water acts like an "adhesive", in order to keep the substrate at the right place on an enzyme.
There are many people in this position and the number is increasing; cancer patients who not only have to fight against cancer, but also suffer from other diseases. So-called comorbidity is a large and growing problem, not least because we are becoming older and age increases the risk of contracting cancer as well as other diseases.
NeuroDerm, Ltd. announced today that enrollment of healthy subjects is ongoing in its Phase I clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously via a subcutaneous delivery patch device. It is designed to provide steady levodopa blood levels and enhanced bioavailability of oral levodopa for the reduction of motor complications in Parkinson's disease.
After over a decade of preclinical research and development, a new gene therapy treatment for Sickle Cell Anemia is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the world where SCA is most common.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Amy Lascelles Heibel, MD 1 Baylor Plz, Houston, TX 77030-3411 Ph: (281) 873-2370 | Dr Amy Lascelles Heibel, MD 1504 Ben Taub Loop, Houston, TX 77030 Ph: (281) 952-0384 |
News Archive
In biologically active enzyme substrate compounds, as can be found in medicines, water plays a more decisive role than has been imagined up to now. The surrounding water acts like an "adhesive", in order to keep the substrate at the right place on an enzyme.
There are many people in this position and the number is increasing; cancer patients who not only have to fight against cancer, but also suffer from other diseases. So-called comorbidity is a large and growing problem, not least because we are becoming older and age increases the risk of contracting cancer as well as other diseases.
NeuroDerm, Ltd. announced today that enrollment of healthy subjects is ongoing in its Phase I clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously via a subcutaneous delivery patch device. It is designed to provide steady levodopa blood levels and enhanced bioavailability of oral levodopa for the reduction of motor complications in Parkinson's disease.
After over a decade of preclinical research and development, a new gene therapy treatment for Sickle Cell Anemia is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the world where SCA is most common.
› Verified 3 days ago
Dr. Michaela Elizabeth Ginn, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 13214 Indian Creek Road, Houston, TX 77079 Phone: 713-591-3555 Fax: 661-321-3286 | |
Ameena Bagree Malhotra, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, 77030-4009, Houston, TX 77030 Phone: 713-792-6161 | |
Svetang Vijay Desai, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 444 Fm 1959 Rd, Suite A, Houston, TX 77034 Phone: 281-481-9400 | |
Dr. Stalin R Subramanian, M.D Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 7200 Cambridge St Fl 8, Houston, TX 77030 Phone: 713-798-0950 | |
Robin Boliver-campbell, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 7141 Southwest Fwy, Houston, TX 77074 Phone: 713-771-7921 Fax: 713-264-8659 | |
Henna Mukhtar Malik, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 13215 Dotson Rd Ste 300, Houston, TX 77070 Phone: 281-894-8822 | |
Zaven Sargsyan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1504 Taub Loop, Houston, TX 77030 Phone: 713-873-8890 |